InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
0.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Blickenstaff Kim d. Director active across 3 companies, notably TANDEM DIABETES CARE INC. Aggregated, 14 filings have been logged. Split: 1 buy · 7 sells. Total volume traded: €8.7m. Activity tracked since 27 May 2021. The latest transaction was filed on 20 November 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Blickenstaff Kim d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
10,000 shares@ US$30.003.0% of flowCommon StockSEC:0001438133-24-000217:0
172,189 shares@ US$2.9043100.0% of flowClass A Common StockSEC:0001415889-24-016680:0
Canonical exit: 9 Sept 2024 (T+90)
4,434 shares@ US$51.732.3% of flowCommon StockSEC:0001438133-24-000119:0
2,757 shares0Common StockSEC:0001438133-23-000111:0
6,560 shares@ US$9.000.0037% mcap0.6% of flowCommon StockSEC:0001438133-22-000087:0
28,400 shares@ US$113.3528.9% of flowCommon StockSEC:0001438133-21-000157:0
28,700 shares@ US$3.500.9% of flowCommon StockSEC:0001438133-21-000155:0
24,240 shares@ US$109.069823.9% of flowCommon StockSEC:0001438133-21-000135:0
13,990 shares@ US$105.499213.4% of flowCommon StockSEC:0001438133-21-000133:0
3,210 shares@ US$107.20693.1% of flowCommon StockSEC:0001438133-21-000129:0
2,800 shares@ US$109.39392.8% of flowCommon StockSEC:0001438133-21-000125:0
10,000 shares@ US$91.518.0% of flowCommon StockSEC:0001438133-21-000102:0
17,123 shares@ US$87.4113.1% of flowCommon StockSEC:0001438133-21-000096:0
1,892 shares0Common StockSEC:0001438133-21-000081:0
14 of 14 declarations
About Blickenstaff Kim d
Blickenstaff Kim D is a declarant and has 14 filings in total. Across the sampled recent filings from 2021-06-01 to 2024-11-22, the buy amount is EUR 465617 and the sell amount is EUR 8277181, with the modal transaction nature listed as Cession. He is a Director at Tandem Diabetes Care INC and a Director at Nuvation Bio Inc.
